Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
COSTS AND EXPENSES:    
Research and development $ 10,671 $ 6,829
General and administrative 3,343 2,867
Total operating expenses 14,014 9,696
Operating loss (14,014) (9,696)
Interest income, net 38 15
NET LOSS $ (13,976) $ (9,681)
Net loss per common share, basic and diluted (in dollars per share) $ (0.74) $ (0.71)
Weighted average common shares outstanding, basic and diluted (in shares) 18,860,429 13,696,482